Updated on 15 October 2026
Drug discovery for new antivirals
International Development Senior Manager at CiMUS
Santiago de Compostela, Spain
About
We offer our capabilities and expertise in early drug discovery to a project willing to develop new small molecules for the treatment of the listed virus. We can contribute with our library of well annotated compounds, assay development expertise and all the in vitro assays required for moving forward a chemical program from hit finding to lead optimization, and including in vivo pharmacokinetics.
Organisation
Similar opportunities
Project cooperation
Biomarkers on liver diseases by omics
- Partner seeks Consortium/Coordinator
- Destination 3: HORIZON-HLTH-2027-02-DISEASE-01-two-stage: Innovative healthcare interventions for non-communicable diseases
- Destination 3: HORIZON-HLTH-2027-01-DISEASE-10: Prevention and management of chronic non-communicable diseases in children and young people (GACD)
- Destination 5: HORIZON-HLTH-2027-02-TOOL-01-two-stage: Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseases
Pablo Giraudi
senior scientist at Fondazione Italiana Fegato
Trieste, Italy
Project cooperation
Metabolic Syndrome - Obesity- MASLD
- Partner seeks Consortium/Coordinator
- Destination 3: HORIZON-HLTH-2027-02-DISEASE-01-two-stage: Innovative healthcare interventions for non-communicable diseases
- Destination 3: HORIZON-HLTH-2027-01-DISEASE-10: Prevention and management of chronic non-communicable diseases in children and young people (GACD)
- Destination 5: HORIZON-HLTH-2027-02-TOOL-01-two-stage: Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseases
Natalia Rosso
Senior researcher -MASLD UNit at Fondazione Italiana Fegato
Trieste, Italy
Project cooperation
- Destination 3: HORIZON-HLTH-2027-01-DISEASE-06: Development of monoclonal antibodies to prevent and treat infections from Flaviviruses
- Destination 3: HORIZON-HLTH-2027-01-DISEASE-07: Development of monoclonal antibodies to prevent and treat infections from Filo-, Nairo-, Phenui-, Picorna- and Toga viruses
Rosa M Osuna Aguilar
Business Development Manager at Biat Group
Jerez de la Fra., Spain